The Affordable Care Act: Building Epidemiology, Laboratory, and Health Information Systems Capacity in the Epidemiology and Laboratory Capacity for Infectious Disease (ELC) and Emerging Infections Program (EIP) Cooperative Agreements; PPHF

 

The Prevention and Public Health Fund (Title IV, Section 4002) was established under the Patient Protection and Affordable Care Act to provide for expanded and sustained national investment in prevention and public health programs to improve health and help restrain the rate of growth in private and public sector health care costs. The Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) and Emerging Infections Program (EIP) cooperative agreements were formed in 1995 as key components of CDC?s national strategy to address and reduce emerging infectious disease (EID) threats. The programs play a critical role in strengthening national infectious disease infrastructure by serving as collaborative platforms for state and local health departments, CDC programs, and academic and various other public health partners to improve the ability to detect and respond to EIDs and other public health threats. Specifically, the programs build epidemiology, laboratory, and information systems capacity, integrate epidemiology and laboratory practice, implement active surveillance, and conduct targeted research aimed at improving methods and informing national surveillance and response activities. Overall, additional funds from multiple sources including PPHF will allow ELC and EIP partner agencies to substantially address gaps in EID epidemiology and laboratory capacity (e.g. number and training level of epi and lab staff, efficient/functional information systems, etc).

Deleted 03/27/2024 (Archived.) 93.521 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Patient Protection and Affordable Care Act (PL 11-148), Title IV, Section 4002 (Prevention and Public Health Fund) for expanded and sustained national investment in prevention and public health programs. This program is funded in part by 2012 Prevention and Public Health Funds (PPHF-2012), Section 301 and 317, 42 U.S.C. 241 and 247b
Sections 301 and 317 of the Public Health Service Act (PHS Act), 42 USC, 241 and 247b as amended; and Funding is appropriated under Affordable Care Act (PL 111-148), Title IV, Section 4002 (Prevention and Public Health Fund), Title IV, Section 4002 Eligible applicants include the current ELC and EIP grantees which consists of all U.S. states, 6 large local health departments (Los Angeles County, Philadelphia, New York City, Chicago, Houston, and the District of Columbia), U.S. territories (Puerto Rico, Guam, U.S. Virgin Islands) and other U.S. affiliates in the Pacific (American Samoa, the Republic of Palau, Federated States of Micronesia, Marshall Islands, Mariana Islands and American Samoa). State health departments, large local health departments, the District of Columbia, U.S. Territories, and the general public. Allowable costs will be determined in accordance with OMB Circular No. A-87 for State, Local, and Indian Tribal governments. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. Only current recipients under CK141401 are eligible to apply. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applications must be submitted electronically via Grant Solutions. Applications that are complete and responsive will be evaluated for scientific and technical merit and receive support. CDC will not review incomplete and non-responsive applications. Applications that are complete and responsive will undergo an objective review process, receive a written critique and be scored according to the published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer. Initial award provides funds for the first budget period (usually 12 months) and the NOA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. About 120 days from receipt of application. Not applicable. Renewals will be based upon availability of funding under the Patient Protection and Affordable Care Act. Applications will be evaluated based on: (1) clearly provide a plan that includes quantitative process and outcome measures (2) provide adequate and clear information to enable the reviewer to gain a reasonable understanding of the applicant's recent and current efforts to address the issues and (3) provide a realistic plan with activities that can be achieved in year one and subsequent years. Other criteria will be listed in the individual funding opportunity announcements. Project funds may be used for costs associated with planning, organizing, and the implementation of other program elements to build public health epidemiology, laboratory, and health information systems capacity. Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. Performance Reports: Federal Financial Reports and Progress Reports are required, no more than 90 days after the end of the budget/project period. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceed $500,000). The grantee should include this requirement in all sub-recipient contracts. Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is available for a 12-month budget period within project periods ranging from one to five years. Method of awarding/releasing assistance: Lump. None/Not specified. Angelica O'Connor
1600 Clifton Rd, NE (MS-C18)
Atlanta, GA 30333 US
AMOConnor@cdc.gov
Phone: 4046397379

Jason Snow
Scientific and Program Services Branch, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Diseases,
Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE, Mailstop C18
Atlanta, GA 30333 US
itk0@cdc.gov
Phone: (404) 639-4577 http://www.cdc.gov 75-0951-0-1-550 (Cooperative Agreements) FY 18$18,845,332.00; FY 19 est $18,845,332.00; FY 20 est $0.00; FY 17$60,145,113.00; FY 16$61,134,448.00; - FY2018 and FY2019estimates only. FY2018 awards were not complete at the time of updating this information. Includes both ELC and EIP awards through 8/1/2018.(Cooperative Agreements) FY 18$18,845,332.00; FY 19 est $18,845,332.00; FY 20 est $0.00; - (Cooperative Agreements) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; - Not applicable/available. Regulations governing this program are published under 42 CFR 55b. Guidelines are available. 45 CFR 92, and also HHS Grants Policy Statement at http://www.ahrq.gov/fund/hhspolicy.htm. Not applicable.